Please enable JavaScript in your web browser settings, under the site permissions section to unlock full site functionality. Click here for help.

Article Image - Valeant Acquisition of Salix Pharmaceuticals

Posted 27th February 2015

Valeant Acquisition of Salix Pharmaceuticals

NULL

Scroll to keep reading

Valeant Acquisition of Salix Pharmaceuticals

Valeant Acquisition of Salix Pharmaceuticals

Valeant Pharmaceuticals International, Inc. and Salix Pharmaceuticals, Ltd. announced that they have entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Salix for $158.00 per share in cash, or a total enterprise value of approximately $14.5 billion. The transaction was approved by the Boards of Directors of both companies.

Salix Pharmaceuticals is a widely recognized gastrointestinal market leader with a portfolio of 22 total products, including well-known prescription brands Xifaxan, Uceris, Relistor, and Apriso, as well as a strong near- term pipeline of innovative, new assets.

“Salix’s market-leading gastrointestinal franchise is an ideal strategic fit for Valeant’s diversified portfolio of specialty products,” said J. Michael Pearson, Valeant’s chairman and chief executive officer. “The growing GI market has attractive fundamentals, and Salix has a portfolio of terrific products that are outpacing the market in terms of volume growth and a promising near-term pipeline of innovative products. With strong brand recognition among specialist GI prescribers, a highly rated specialty sales force, and a significant product and commercial presence across the undertreated and underserved gastrointestinal market, this acquisition offers a compelling opportunity for Valeant to create a strong platform for growth and business development.”

Thomas W. D’Alonzo, Chairman of the Board and Acting Chief Executive Officer of Salix, stated, “We are pleased to have reached an agreement with Valeant, which is a logical partner and importantly, creates immediate value for our shareholders. Combining Salix’s leading market position in gastroenterology with Valeant’s scale and resources will create a stronger and more diverse business committed to providing better health solutions to health care providers and their patients. We are proud of the accomplishments of our Salix team. Together, we have built our company into the leading gastrointestinal specialty pharmaceutical company, providing solutions for patients and healthcare providers. We look forward to working with the Valeant team to ensure a smooth transition.”

To find out more information about either company, please visit www.valeant.com or www.salix.com.

Categories: M&A, Strategy

You Might Also Like

Cybersecurity on the high seas

26/04/2019Cybersecurity on the high seas

With their preference for hijacks, machine-gun-point robbery and hostage-taking ransoms, 21st-century pirates on the high seas are a far cry from the pirates that we have all heard and read about.

Are law firms being proactive enough when it comes to cyber security?

01/04/2021Are law firms being proactive enough when it comes to cyber security?

Lockdown working has exposed the gaps in cyber security practices in many law firms. With hackers looking for a pay day, it’s never too late to become cyber proactive. Guy Lloyd at CySure explains why cyber security doesn’t need to be complex, costly or co

2016’s Most Innovative Hedge Fund Manager, UK

30/06/20162016’s Most Innovative Hedge Fund Manager, UK

AIM is a UK-based asset manager, founded in 2008 by a long-standing team that had formerly managed $6 billion at UBS and $2 billion at Insight.

It’s All About Educating the Mind

10/10/2016It’s All About Educating the Mind

Neurocoaching was founded and built by Patricia López, a mentor-coach, and telecommunications engineer for more than 20 years. The company is focused on developing engineers, whether it be getting the know themselves, skills, beliefs, or achieving their goals

VTech to Acquire LeapFrog Enterprises

05/02/2016VTech to Acquire LeapFrog Enterprises

VTech Holdings Limited, aleader in electronic learning products and cordless telephones,and LeapFrog Enterprises, Inc, a developer of educational entertainment for children, announces today that the two companies have entered into a merger agreement whereby VT

Resolving Disputes Through Arbitration

16/05/2016Resolving Disputes Through Arbitration

More than ever before, companies across the financial landscape are realising the benefits of alternative dispute resolution.

Changing Perception On Collecting Information

28/01/2020Changing Perception On Collecting Information

Conventionally, data mining in biomedicine in the ‘omics’ era refers to a bioinformatics approach that combines key concepts of biology with advanced computer tools or statistical methods that are primarily used to discover, select and prioritize targets.

31/08/2016Taxing Times

Base in Istanbul, Nazali Tax and Legal Services is a highly renowned firm who provide a wide range of consultancy and litigation services both nationally and internationally.

Rural Businesses in UK Are Struggling According To Recent Survey

28/04/2023Rural Businesses in UK Are Struggling According To Recent Survey

Rural businesses in the UK are struggling to compete with their urban counterparts due to a lack of public infrastructure and skilled labour, according to a recent survey by the British Chambers of Commerce (BCC) and small business platform Xero.

View More Articles

Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

MORE BRANDS